WASHINGTON (Reuters) - Abbott Laboratories Inc won a U.S. panel's support on Tuesday for wider use of its blockbuster rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback